<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33919184</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>21</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">720</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13050720</ELocationID><Abstract><AbstractText>Enterovirus A-71 (EV71) is a global, highly contagkkious pathogen responsible for severe cases of hand-food-mouth-disease (HFMD). The use of vaccines eliciting cross neutralizing antibodies (NTAbs) against the different circulating EV71 sub-genotypes is important for preventing HFMD outbreaks. Here, we tested the cross-neutralizing activities induced by EV71 genotype/sub-genotype A, B0-B4, C1, C2, C4, and C5 viruses using rats. Differences were noted in the cross-neutralization of the 10 sub-genotypes tested but there were generally good levels of cross-neutralization except against genotype A virus, against which neutralization antibody titres (NTAb) where the lowest with NTAbs being the highest against sub-genotype B4. Moreover, NTAb responses induced by C4, B4, C1, and C2 viruses were homogenous, with values of maximum/minimum NTAb ratios (MAX/MIN) against all B and C viruses ranging between 4.0 and 6.0, whereas MAX/MIN values against B3 and A viruses were highly variable, 48.0 and 256.0, respectively. We then dissected the cross-neutralizing ability of sera from infants and children and rats immunized with C4 EV71 vaccines. Cross-neutralizing titers against the 10 sub-genotypes were good in both vaccinated infants and children and rats with the MAX/MIN ranging from 1.8-3.4 and 5.1-7.1, respectively, which were similar to those found in naturally infected patients (2.8). Therefore, we conclude that C4 EV71 vaccines can provide global protection to infants and children against HFMD caused by different sub-genotypes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Pei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control, Beijing 102600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yadi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control, Beijing 102600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Bopei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control, Beijing 102600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Yaqian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control, Beijing 102600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bian</LastName><ForeName>Lianlian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control, Beijing 102600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Minhai Biotechnology CO., LTD, Beijing 102600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Siyuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control, Beijing 102600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chenfei</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control, Beijing 102600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yingzhi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Minhai Biotechnology CO., LTD, Beijing 102600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedcastle</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire EN6 3QG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control, Beijing 102600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Qunying</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control, Beijing 102600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5326-7081</Identifier><AffiliationInfo><Affiliation>Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire EN6 3QG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Zhenglun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control, Beijing 102600, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071497" MajorTopicYN="N">Immunogenicity, Vaccine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cross-neutralization</Keyword><Keyword MajorTopicYN="N">enterovirus 71 (EV71)</Keyword><Keyword MajorTopicYN="N">genotype</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33919184</ArticleId><ArticleId IdType="pmc">PMC8143144</ArticleId><ArticleId IdType="doi">10.3390/v13050720</ArticleId><ArticleId IdType="pii">v13050720</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Klein M., Chong P. Is a multivalent hand, foot, and mouth disease vaccine feasible? Hum. Vaccines Immunother. 2015;11:2688&#x2013;2704. doi: 10.1080/21645515.2015.1049780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2015.1049780</ArticleId><ArticleId IdType="pmc">PMC4685682</ArticleId><ArticleId IdType="pubmed">26009802</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip C.C., Lau S.K., Zhou B., Zhang M.X., Tsoi H.W., Chan K.H., Chen X.C., Woo P.C., Yuen K.Y. Emergence of enterovirus 71 &#x201c;double-recombinant&#x201d; strains belonging to a novel genotype D originating from southern China: First evidence for combination of intratypic and intertypic recombination events in EV71. Arch. Virol. 2010;155:1413&#x2013;1424. doi: 10.1007/s00705-010-0722-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-010-0722-0</ArticleId><ArticleId IdType="pmc">PMC7087135</ArticleId><ArticleId IdType="pubmed">20549263</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessaud M., Razafindratsimandresy R., Nougair&#xe8;de A., Joffret M.L., Deshpande J.M., Dubot-P&#xe9;r&#xe8;s A., H&#xe9;raud J.M., de Lamballerie X., Delpeyroux F., Bailly J.L. Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity. PLoS ONE. 2014;9:e90624. doi: 10.1371/journal.pone.0090624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0090624</ArticleId><ArticleId IdType="pmc">PMC3944068</ArticleId><ArticleId IdType="pubmed">24598878</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S.S., Yip C.C., Lau S.K., Yuen K.Y. Human enterovirus 71 and hand, foot and mouth disease. Epidemiol. Infect. 2010;138:1071&#x2013;1089. doi: 10.1017/S0950268809991555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268809991555</ArticleId><ArticleId IdType="pubmed">20056019</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P., Liu C.C., Chow Y.H., Chou A.H., Klein M. Review of enterovirus 71 vaccines. Clin. Infect. Dis. 2015;60:797&#x2013;803. doi: 10.1093/cid/ciu852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu852</ArticleId><ArticleId IdType="pubmed">25352588</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N.J., Lennette E.H., Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 1974;129:304&#x2013;309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Yeo A., Phoon M.C., Tan E.L., Poh C.L., Quak S.H., Chow V.T. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: The role of enterovirus 71 and coxsackievirus A strains. Int. J. Infect. Dis. 2010;14:e1076&#x2013;e1081. doi: 10.1016/j.ijid.2010.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.07.006</ArticleId><ArticleId IdType="pubmed">20952237</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang L.W., Phoon M.C., Wu Y., Cutter J., James L., Chow V.T. The changing seroepidemiology of enterovirus 71 infection among children and adolescents in Singapore. BMC Infect. Dis. 2011;11:270. doi: 10.1186/1471-2334-11-270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-11-270</ArticleId><ArticleId IdType="pmc">PMC3198955</ArticleId><ArticleId IdType="pubmed">21988931</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Lu S., Xian J., Ye J., Xiao L., Luo J., Zen K., Liu F. Complete genome sequence of a human enterovirus 71 strain isolated in wuhan, china, in 2010. Genome Announc. 2013;1:e01112-13. doi: 10.1128/genomeA.01112-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/genomeA.01112-13</ArticleId><ArticleId IdType="pmc">PMC3873616</ArticleId><ArticleId IdType="pubmed">24371206</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia M.Y., Chiang P.S., Chung W.Y., Luo S.T., Lee M.S. Epidemiology of enterovirus 71 infections in Taiwan. Pediatr. Neonatol. 2014;55:243&#x2013;249. doi: 10.1016/j.pedneo.2013.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedneo.2013.07.007</ArticleId><ArticleId IdType="pubmed">24120535</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tu P., Thao N.T.T., Perera D., Truong K.H., Tien N.T.K., Thuong T.C., How O.M., Cardosa M.J., McMinn P.C. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg. Infect. Dis. 2007;13:1733&#x2013;1741. doi: 10.3201/eid1311.070632.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1311.070632</ArticleId><ArticleId IdType="pmc">PMC3375788</ArticleId><ArticleId IdType="pubmed">18217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K., Abiko C., Murata T., Matsuzaki Y., Itagaki T., Sanjoh K., Sakamoto M., Hongo S., Murayama S., Hayasaka K. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J. Clin. Microbiol. 2005;43:6171&#x2013;6175. doi: 10.1128/JCM.43.12.6171-6175.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.43.12.6171-6175.2005</ArticleId><ArticleId IdType="pmc">PMC1317214</ArticleId><ArticleId IdType="pubmed">16333123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.H. Enterovirus 71 infection: An experience in Korea, 2009. Korean J. Pediatr. 2010;53:616&#x2013;622. doi: 10.3345/kjp.2010.53.5.616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2010.53.5.616</ArticleId><ArticleId IdType="pmc">PMC2994121</ArticleId><ArticleId IdType="pubmed">21189926</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., Shih S.R. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 1999;341:929&#x2013;935. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Commission of the People&#x2019;s Republic of China.  [(accessed on 26 February 2018)]; Available online:  http://www.nhc.gov.cn/jkj/s3578/201802/de926bdb046749abb7b0a8e23d929104.shtml.</Citation></Reference><Reference><Citation>Mao Q.Y., Gao F., He P.F., Liang Z.L., Xu M. Background and key-point for WHO issued recommendations for the quality, safety and efficacy of enterovirus 71 vaccines (inactivated) Chin. J. Biol. 2021;34:121&#x2013;126.</Citation></Reference><Reference><Citation>Mao Q.Y., Wang Y., Bian L., Xu M., Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) Expert Rev. Vaccines. 2016;15:599&#x2013;606. doi: 10.1586/14760584.2016.1138862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F.C., Meng F.Y., Li J.X., Li X.L., Mao Q.Y., Tao H., Zhang Y.T., Yao X., Chu K., Chen Q.H., et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381:2024&#x2013;2032. doi: 10.1016/S0140-6736(13)61049-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61049-1</ArticleId><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., Xu W., Xia J., Liang Z., Liu Y., Zhang X., Tan X., Wang L., Mao Q., Wu J., et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N. Engl. J. Med. 2014;370:818&#x2013;828. doi: 10.1056/NEJMoa1304923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Liu L., Mo Z., Wang X., Xia J., Liang Z., Zhang Y., Li Y., Mao Q., Wang J., et al. An inactivated enterovirus 71 vaccine in healthy children. N. Engl. J. Med. 2014;370:829&#x2013;837. doi: 10.1056/NEJMoa1303224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Commission of the People&#x2019;s Republic of China  National Notifiable Infectious Diseases.  [(accessed on 12 March 2021)]; Available online:  http://www.nhc.gov.cn/jkj/s3578/202103/f1a448b7df7d4760976fea6d55834966.shtml.</Citation></Reference><Reference><Citation>Zhifang L., Juanjuan G., Qihang H. Molecular epidemiology and evolution of human enterovirus 71 and hand, foot and mouth disease. Hereditas. 2015;37:426&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pubmed">25998430</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Sanden S., Koopmans M., Uslu G., van der Avoort H., Dutch Working Group for Clinical Virology Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008. J. Clin. Microbiol. 2009;47:2826&#x2013;2833. doi: 10.1128/JCM.00507-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00507-09</ArticleId><ArticleId IdType="pmc">PMC2738086</ArticleId><ArticleId IdType="pubmed">19625480</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B.A., Oberste M.S., Alexander J.-J., Kennett M.L., Pallansch M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 1999;73:9969&#x2013;9975. doi: 10.1128/JVI.73.12.9969-9975.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.12.9969-9975.1999</ArticleId><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapusinszky B., Szomor K.N., Farkas A., Tak&#xe1;cs M., Berencsi G. Detection of non-polio enteroviruses in Hungary 2000-2008 and molecular epidemiology of enterovirus 71, coxsackievirus A16, and echovirus 30. Virus Genes. 2010;40:163&#x2013;173. doi: 10.1007/s11262-009-0440-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-009-0440-4</ArticleId><ArticleId IdType="pubmed">20044791</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosoya M., Kawasaki Y., Sato M., Honzumi K., Kato A., Hiroshima T., Ishiko H., Suzuki H. Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. Pediatr. Infect. Dis. J. 2006;25:691&#x2013;694. doi: 10.1097/01.inf.0000227959.89339.c3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000227959.89339.c3</ArticleId><ArticleId IdType="pubmed">16874167</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H., Utama A., Onnimala N., Li C., Li-Bi Z., Yu-Jie M., Pongsuwanna Y., Miyamura T. Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr. Int. 2004;46:231&#x2013;235. doi: 10.1046/j.1442-200x.2004.01868.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1442-200x.2004.01868.x</ArticleId><ArticleId IdType="pubmed">15056257</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders S.A., Herrero L.J., McPhie K., Chow S.S., Craig M.E., Dwyer D.E., Rawlinson W., McMinn P.C. Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community. Arch. Virol. 2006;151:1003&#x2013;1013. doi: 10.1007/s00705-005-0684-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-005-0684-9</ArticleId><ArticleId IdType="pubmed">16369861</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan Y.F., Wee K.L., Chiam C.W., Khor C.S., Chan S.Y., Amalina W.M.Z., Sam I.C. Comparative genetic analysis of VP4, VP1 and 3D gene regions of enterovirus 71 and coxsackievirus A16 circulating in Malaysia between 1997&#x2013;2008. Trop. Biomed. 2012;29:451&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">23018509</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Luo Z., Wang J., Xu Z., Chen H., Fan D., Gao N., Ping G., Zhou Z., Zhang Y., et al. Phylogenetic analysis of Enterovirus 71 circulating in Beijing, China from 2007 to 2009. PLoS ONE. 2013;8:e56318. doi: 10.1371/journal.pone.0056318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0056318</ArticleId><ArticleId IdType="pmc">PMC3572022</ArticleId><ArticleId IdType="pubmed">23418551</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Tan X.J., Wang H.Y., Yan D.M., Zhu S.L., Wang D.Y., Ji F., Wang X.J., Gao Y.J., Chen L., et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J. Clin. Virol. 2009;44:262&#x2013;267. doi: 10.1016/j.jcv.2009.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2009.02.002</ArticleId><ArticleId IdType="pubmed">19269888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhu Z., Yang W., Ren J., Tan X., Wang Y., Mao N., Xu S., Zhu S., Cui A., et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol. J. 2010;7:94. doi: 10.1186/1743-422X-7-94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardosa M.J., Perera D., Brown B.A., Cheon D., Chan H.M., Chan K.P., Cho H., McMinn P. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: Comparative analysis of the VP1 and VP4 genes. Emerg. Infect. Dis. 2003;9:461&#x2013;468. doi: 10.3201/eid0904.020395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0904.020395</ArticleId><ArticleId IdType="pmc">PMC2957976</ArticleId><ArticleId IdType="pubmed">12702227</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Li C., He D., Cheng T., Ge S., Shih J.W., Zhao Q., Chen P.J., Zhang J., Xia N. Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: Current genotyping of EV71 does not reflect their antigenicity. Vaccine. 2013;31:425&#x2013;430. doi: 10.1016/j.vaccine.2012.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.10.032</ArticleId><ArticleId IdType="pubmed">23088887</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q.Y., Guo Z.B., Hao C.S., Yu D., Gao F., Xie Z.P., Li X.L., Liang Z.L. Screening and preparation of candidate standard strain for determination of neutralizing antibody against enterovirus 71. Chin. J. Biol. 2012;25:725&#x2013;729.</Citation></Reference><Reference><Citation>Mizuta K., Aoki Y., Suto A., Ootani K., Katsushima N., Itagaki T., Ohmi A., Okamoto M., Nishimura H., Matsuzaki Y., et al. Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine. 2009;27:3153&#x2013;3158. doi: 10.1016/j.vaccine.2009.03.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.03.060</ArticleId><ArticleId IdType="pubmed">19446185</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Sanden S., van der Avoort H., Lemey P., Uslu G., Koopmans M. Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses. J. Gen. Virol. 2010;91:1949&#x2013;1958. doi: 10.1099/vir.0.019695-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.019695-0</ArticleId><ArticleId IdType="pubmed">20375223</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia M.Y., Chung W.Y., Chiang P.S., Chien Y.S., Ho M.S., Lee M.S. Monitoring antigenic variations of enterovirus 71: Implications for virus surveillance and vaccine development. PLoS Negl. Trop. Dis. 2014;8:e3044. doi: 10.1371/journal.pntd.0003044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003044</ArticleId><ArticleId IdType="pmc">PMC4109910</ArticleId><ArticleId IdType="pubmed">25058733</ArticleId></ArticleIdList></Reference><Reference><Citation>Salk J.E. Considerations in the preparation and use of poliomyelitis virus vaccine. JAMA. 1984;158:1239&#x2013;1248. doi: 10.1001/jama.1955.02960140001001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1955.02960140001001</ArticleId><ArticleId IdType="pubmed">14392073</ArticleId></ArticleIdList></Reference><Reference><Citation>Krugman S., Warren J., Eiger M.S., Berman P.H., Michaels R.M., Sabin A.B. Immunization with live attenuated poliovirus vaccine. Am. J. Dis. Child. 1961;101:23&#x2013;29. doi: 10.1001/archpedi.1961.04020020025005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.1961.04020020025005</ArticleId><ArticleId IdType="pubmed">13754588</ArticleId></ArticleIdList></Reference><Reference><Citation>Innis B.L., Snitbhan R., Kunasol P., Laorakpongse T., Poopatanakool W., Kozik C.A., Suntayakorn S., Suknuntapong T., Safary A., Tang D.B. Protection against hepatitis A by an inactivated vaccine. JAMA. 1994;271:1328&#x2013;1334. doi: 10.1001/jama.1994.03510410040030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1994.03510410040030</ArticleId><ArticleId IdType="pubmed">8158817</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou A.H., Liu C.C., Chang J.Y., Jiang R., Hsieh Y.C., Tsao A., Wu C.L., Huang J.L., Fung C.P., Hsieh S.M., et al. Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers. PLoS ONE. 2013;8:e79783. doi: 10.1371/journal.pone.0079783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079783</ArticleId><ArticleId IdType="pmc">PMC3836818</ArticleId><ArticleId IdType="pubmed">24278177</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q., Cheng T., Zhu F., Li J., Wang Y., Li Y., Gao F., Yang L., Yao X., Shao J., et al. The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children. PLoS ONE. 2013;8:e79599. doi: 10.1371/journal.pone.0079599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079599</ArticleId><ArticleId IdType="pmc">PMC3834186</ArticleId><ArticleId IdType="pubmed">24260259</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>